Skip to main content
SpringerLink
Log in

Hämodiafiltration vs. Hämodialyse bei terminalem Nierenversagen

Überzeugt CONVINCE?

Hemodiafiltration vs. Hemodialysis in end-stage renal disease

Is CONVINCE convincing?

  • Für Sie gelesen
  • Published:
Die Nephrologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Caskey FJ et al (2022) The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes. Trials 23:532. https://doi.org/10.1186/s13063-022-06357-y

    Article  PubMed  PubMed Central  Google Scholar 

  2. ESHOL Study Group, Maduell F et al (2013) High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 24(3):487. https://doi.org/10.1681/asn.2012080875

    Article  Google Scholar 

  3. HDF Pooling Project Investigators, Peters SAE et al (2016) Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials. Nephrol Dial Transplant 31:978–984. https://doi.org/10.1093/ndt/gfv349

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin I, Schön Klinik Rendsburg, Lilienstr. 20–28, 24768, Rendsburg, Deutschland

    Sophie Preisker

Authors
  1. Sophie Preisker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sophie Preisker.

Ethics declarations

Interessenkonflikt

S. Preisker gibt an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

Thorsten Feldkamp, Rendsburg-Eckernförde

Jens Lutz, Bremen

Lutz T. Weber, Köln

Hinweis des Verlags

Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Preisker, S. Hämodiafiltration vs. Hämodialyse bei terminalem Nierenversagen. Nephrologie (2024). https://doi.org/10.1007/s11560-024-00724-3

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11560-024-00724-3

Search

Navigation